BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8310762)

  • 1. Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.
    Alonso de Velasco E; Verheul AF; Veeneman GH; Gomes LJ; van Boom JH; Verhoef J; Snippe H
    Vaccine; 1993 Nov; 11(14):1429-36. PubMed ID: 8310762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
    Alonso de Velasco E; Verheul AF; van Steijn AM; Dekker HA; Feldman RG; Fernández IM; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H
    Infect Immun; 1994 Mar; 62(3):799-808. PubMed ID: 7509318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.
    Jansen WT; Hogenboom S; Thijssen MJ; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H; Verheul AF
    Infect Immun; 2001 Feb; 69(2):787-93. PubMed ID: 11159969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice.
    Benaissa-Trouw B; Lefeber DJ; Kamerling JP; Vliegenthart JF; Kraaijeveld K; Snippe H
    Infect Immun; 2001 Jul; 69(7):4698-701. PubMed ID: 11402020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revised interpretation of the immunological results obtained with pneumococcal polysaccharide 17F derived synthetic di-, tri- and tetrasaccharide conjugates in mice and rabbits.
    Jansen WT; Verheul AF; Veeneman GH; van Boom JH; Snippe H
    Vaccine; 2001 Oct; 20(1-2):19-21. PubMed ID: 11567741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
    Snippe H; van Houte AJ; van Dam JE; De Reuver MJ; Jansze M; Willers JM
    Infect Immun; 1983 Jun; 40(3):856-61. PubMed ID: 6852923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.
    Peeters CC; Tenbergen-Meekes AM; Evenberg DE; Poolman JT; Zegers BJ; Rijkers GT
    J Immunol; 1991 Jun; 146(12):4308-14. PubMed ID: 2040803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to
    Kurbatova EA; Akhmatova NK; Zaytsev AE; Akhmatova EA; Egorova NB; Yastrebova NE; Sukhova EV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
    Front Immunol; 2020; 11():578019. PubMed ID: 33343566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonionic block polymer surfactants modulate the humoral immune response against Streptococcus pneumoniae-derived hexasaccharide-protein conjugates.
    Zigterman GJ; Schotanus K; Ernste EB; Van Dam GJ; Jansze M; Snippe H; Willers JM
    Infect Immun; 1989 Sep; 57(9):2712-8. PubMed ID: 2759707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates.
    Peeters C; Tenbergen-Meekes AM; Poolmann J; Zegers B; Rijkers G
    Med Microbiol Immunol; 1992; 181(1):35-42. PubMed ID: 1579084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SYNTHETIC CONJUGATED ANALOGUES OF CAPSULE POLYSACCHARIDES OF PNEUMOCOCCUS - AN INSTRUMENT FOR DETECTION OF POST-VACCINATION ANTIBODIES].
    Kurbatova EA; Akhmatova EA; Akhmatova NK; Egorova NB; Yastrebova NE; Sukhova EV; Tsvetkov YE; Yashunsky DV; Nifantiev NE
    Zh Mikrobiol Epidemiol Immunobiol; 2016 Nov; (6):54-60. PubMed ID: 30695390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates.
    Verheul AF; Versteeg AA; De Reuver MJ; Jansze M; Snippe H
    Infect Immun; 1989 Apr; 57(4):1078-83. PubMed ID: 2925240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate Specificity and Isotypes of Monoclonal and Polyclonal Antibodies to Conjugated Tetrasaccharide, a Synthetic Analogue of Repeating Unit of Capsular Polysaccharide of Streptococcus Pneumoniae Serotype 14.
    Kurbatova ЕА; Yakovleva IV; Akhmatova EА; Sukhova ЕV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
    Bull Exp Biol Med; 2019 Feb; 166(4):477-480. PubMed ID: 30788740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses.
    Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H
    Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.
    Paoletti LC; Kasper DL; Michon F; DiFabio J; Jennings HJ; Tosteson TD; Wessels MR
    J Clin Invest; 1992 Jan; 89(1):203-9. PubMed ID: 1729272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response.
    Rodriguez ME; van den Dobbelsteen GP; Oomen LA; de Weers O; van Buren L; Beurret M; Poolman JT; Hoogerhout P
    Vaccine; 1998 Dec; 16(20):1941-9. PubMed ID: 9796048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype 11 capsular polysaccharide.
    Zigterman JW; van Dam JE; Snippe H; Rotteveel FT; Jansze M; Willers JM; Kamerling JP; Vliegenthart JF
    Infect Immun; 1985 Feb; 47(2):421-8. PubMed ID: 3881349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity and gene expression related to pneumococcal glycoconjugate.
    Lee CJ; Li ZM
    Adv Exp Med Biol; 2001; 491():505-14. PubMed ID: 14533818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.